These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 20010854)

  • 21. Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity.
    Gangavarapu KJ; Azabdaftari G; Morrison CD; Miller A; Foster BA; Huss WJ
    Stem Cell Res Ther; 2013 Oct; 4(5):132. PubMed ID: 24405526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and clinical relevance of ALDHbright populations in prostate cancer.
    Le Magnen C; Bubendorf L; Rentsch CA; Mengus C; Gsponer J; Zellweger T; Rieken M; Thalmann GN; Cecchini MG; Germann M; Bachmann A; Wyler S; Heberer M; Spagnoli GC
    Clin Cancer Res; 2013 Oct; 19(19):5361-71. PubMed ID: 23969936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
    Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
    Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1.
    Okamoto A; Funakoshi Y; Oe M; Takai R; Suto H; Nagatani Y; Nishimura M; Imamura Y; Kunihisa T; Kiyota N; Miki K; Ohe K; Tanino H; Minami H
    Anticancer Res; 2022 Mar; 42(3):1199-1205. PubMed ID: 35220209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
    Althobiti M; El Ansari R; Aleskandarany M; Joseph C; Toss MS; Green AR; Rakha EA
    Histopathology; 2020 Sep; 77(3):437-448. PubMed ID: 32369651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma.
    Sharbatoghli M; Shamshiripour P; Fattahi F; Kalantari E; Habibi Shams Z; Panahi M; Totonchi M; Asadi-Lari Z; Madjd Z; Saeednejad Zanjani L
    J Ovarian Res; 2022 Jan; 15(1):17. PubMed ID: 35090523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems.
    Levi BP; Yilmaz OH; Duester G; Morrison SJ
    Blood; 2009 Feb; 113(8):1670-80. PubMed ID: 18971422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum ALDH1A1 is a tumor marker for the diagnosis of non-small cell lung cancer.
    Cao YT; Li JH; Wang YT; Fu YW; Xu J
    Tumori; 2014; 100(2):214-8. PubMed ID: 24852868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastoma.
    Schäfer A; Teufel J; Ringel F; Bettstetter M; Hoepner I; Rasper M; Gempt J; Koeritzer J; Schmidt-Graf F; Meyer B; Beier CP; Schlegel J
    Neuro Oncol; 2012 Dec; 14(12):1452-64. PubMed ID: 23132408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.
    Duong HQ; Hwang JS; Kim HJ; Kang HJ; Seong YS; Bae I
    Int J Oncol; 2012 Sep; 41(3):855-61. PubMed ID: 22710732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression.
    Liu C; Qiang J; Deng Q; Xia J; Deng L; Zhou L; Wang D; He X; Liu Y; Zhao B; Lv J; Yu Z; Lei QY; Shao ZM; Zhang XY; Zhang L; Liu S
    Cancer Res; 2021 Dec; 81(23):5919-5934. PubMed ID: 34580061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.
    Huang EH; Hynes MJ; Zhang T; Ginestier C; Dontu G; Appelman H; Fields JZ; Wicha MS; Boman BM
    Cancer Res; 2009 Apr; 69(8):3382-9. PubMed ID: 19336570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma.
    Xu SL; Zeng DZ; Dong WG; Ding YQ; Rao J; Duan JJ; Liu Q; Yang J; Zhan N; Liu Y; Hu QP; Zhang X; Cui YH; Kung HF; Yu SC; Bian XW
    Int J Clin Exp Pathol; 2014; 7(6):2976-86. PubMed ID: 25031716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
    Yang W; Wang Y; Wang W; Chen Z; Bai G
    Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia.
    Bartley AN; Parikh N; Hsu CH; Roe DJ; Buckmeier JA; Corley L; Phipps RA; Gallick G; Lance P; Thompson PA; Hamilton SR
    Cancer Prev Res (Phila); 2013 Nov; 6(11):1162-70. PubMed ID: 24008128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALDH1A1 maintains the cancer stem-like cells properties of esophageal squamous cell carcinoma by activating the AKT signal pathway and interacting with β-catenin.
    Wang W; He S; Zhang R; Peng J; Guo D; Zhang J; Xiang B; Li L
    Biomed Pharmacother; 2020 May; 125():109940. PubMed ID: 32044720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldehyde dehydrogenase 1A1 in stem cells and cancer.
    Tomita H; Tanaka K; Tanaka T; Hara A
    Oncotarget; 2016 Mar; 7(10):11018-32. PubMed ID: 26783961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity.
    Lee MC; Gardner SH; Tapia Hernandez R; Chan J
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 37067271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High ALDH1A1 expression correlates with poor survival in papillary thyroid carcinoma.
    Xing Y; Luo DY; Long MY; Zeng SL; Li HH
    World J Surg Oncol; 2014 Feb; 12():29. PubMed ID: 24485040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.